Examines response to an agreement between Diversa Corp., a biotechnology company, and Yellowstone National Park, which would allow Diversa to use microbes for commercial purposes; includes laws on technology transfer and National Parks, and the role of National Parks; US.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.